Food Insecurity Is Highly Prevalent Amongst Patients With Chronic Liver Disease in Northern England: A
Rachel Howarth1, Thomas Crame1, Stuart McPherson1,2
1Newcastle NIHR Biomedical Research Centre, Newcastle upon Tyne Hospitals, NHS Trust, Newcastle upon Tyne, UK.
Food insecurity (FI) affects 24% of liver disease patients, linked to alcohol-related liver disease, MASLD, and cirrhosis. Addressing FI is crucial for patient care and treatment adherence.
Area of Science:
- Hepatology
- Public Health
- Nutritional Science
Background:
- Liver disease disproportionately impacts economically disadvantaged populations.
- Food insecurity (FI) prevalence has significantly increased globally since 2019.
- FI negatively affects nutritional status and adherence to dietary recommendations.
Purpose of the Study:
- To determine the prevalence of food insecurity among patients with liver disease.
- To identify factors associated with food insecurity in this patient group.
Main Methods:
- A cross-sectional study was conducted with 426 patients at a tertiary hepatology outpatient service.
- Validated tools, including the USDA Six-item Household Food Security Survey, assessed food security.
- Logistic regression analysis identified associations between FI and clinico-sociodemographic variables.
Main Results:
- 24% (103/426) of patients screened were identified as food insecure.
- Factors associated with FI included high-risk alcohol intake, alcohol-related liver disease (ArLD), cirrhosis, and depression.
- Adjusted analyses confirmed associations between FI and ArLD, metabolic dysfunction-associated steatotic liver disease (MASLD), and cirrhosis.
Conclusions:
- Food insecurity is more prevalent in liver disease patients compared to the general population.
- FI is significantly associated with ArLD, MASLD, and cirrhosis, presenting a paradox of contributing to obesity and end-organ damage while compromising nutrition.
- Healthcare providers must incorporate FI assessment into holistic patient evaluations to improve outcomes and treatment adherence.
More Related Videos
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
04:14Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
Published on: April 16, 2019
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Chronic Pancreatitis II: Collaborative Care
Assessment:
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
